U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07412548) titled 'Autogenic Relaxation and Murottal Therapy in Hemodialysis Patients' on Jan. 27.
Brief Summary: This quasi-experimental study aims to evaluate the effect of combined autogenic relaxation and Surah Ar-Rahman murottal therapy on anxiety, sleep quality, and hemodynamic parameters in hemodialysis patients. A pretest-posttest control group design will be used involving 76 participants undergoing routine hemodialysis. Participants will be assigned to an intervention group receiving structured autogenic relaxation followed by murottal therapy and a control group receiving standard care with music listening. Anxiety, sleep quality, and hemod...